logo cancerTo convegno medico 2018 Torino


Deadline: 20th February 2020.

Language: Submission and presentation in English.

Size: Max. 3,000 characters incl. tables and images

Structure: Title, objectives, methods, results, conclusions.

Note: It is not allowed to mention product or company names or any names of the author or of the institution in the text/paper. This will automatically lead to a rejection of the paper.

Publication: Results that have already been published cannot be submitted.

Abstract review: Anonymously by several experts. Criteria are: “Interest of the subject” (new or interesting or already known), “quality of the methodology” (excellent or fair or inadequate), “results” (well-presented and documented or fair or inadequate) and “conclusions” (important or interesting but not new or does not reflect the results). Abstracts that show formal errors (multi-submission for the same congress, not anonymised, with product or company names, already published elsewhere), are going to be rejected.

PRIZES: Among the accepted Abstracts, three will be selected for the following prizes:

-BEST “JUST THE WOMAN I AM” CONTRIBUTION, dedicated to research focusing on women-related cancers

Awardees will be nominated by a scientific committee and will be granted a prize, courtesy of the sponsors.

CONFERENCE PROCEEDINGS: All the accepted Abstracts will be published, free of charge, into a e-Book of Proceeding by the Editor Frontiers

SPECIAL ISSUES: All the registered people and attendants of the conference are warmly invited to submit a full manuscript (Short Communication, Full Research Paper, Review) on the topic related to the CancerTO conference to one of the following journals:

Special issue title: Advances on cancer molecular mechanisms and immunotherapy

Editors: Prof. Marco Deriu, Prof. Valeria Chiono, Dr. Tania Limongi, Dr. Irene Carmagnola, Prof. Paola Cappello

(The link to the Special Issue page and mode of submission will be provided soon)

Special issue title: Emerging technologies for immunotherapy treatment targeting cancer

Editors: Prof. Valentina Cauda, Prof. Marco Deriu, Prof. Valeria Chiono,Dr. Clara Mattu, Prof. Giulia Adriani

Link to the Special Issue

The Manuscripts will be reviewed in a conventional peer-review process and be published in OPEN ACCESS format.

Discount on the Article Processing Charge will be guaranteed.


Submit your abstract


Made with CUS Torino